Skip to content

Pharminent

cropped-neurology_aaic_banner_frontpage_2026-07-15-1.png
Primary Menu
  • Home
  • Signal News
  • Biopharma Brief
    • Market Access Intelligence
    • Rare Disease Gene Therapy
    • Oncology
  • Week in Review
    • GLP-1 Competitive Market
    • NeuroMarket Pulse
      • Neurology Interactive Calendar
    • Manufacturing Intelligence
  • Contact
Light/Dark Button
Brief
  • Home
  • Policy / Pricing
  • Trump signs order that nearly halves childhood immunisation coverage
  • Policy / Pricing

Trump signs order that nearly halves childhood immunisation coverage

Pharmaceutical Technology

Seven diseases have been stripped from the recommendations, with changes to the MMR vaccine also advised.

Infectious Disease

Read full story

pharminent August 11, 2026 (Last updated: August 14, 2026)

Pharmaceutical Technology

Seven diseases have been stripped from the recommendations, with changes to the MMR vaccine also advised.

Infectious Disease

Read full story

Post navigation

Previous: UK regulators greenlight Lilly’s Foundayo, intensifying Novo competition
Next: Epicrispr lands $90M to advance epigenetic editing drug for rare muscle disease

Related Stories

  • Policy / Pricing

Prior Authorization Metrics Provide New Insights into Insurer Practices, but Gaps Remain

pharminent August 13, 2026
  • Policy / Pricing

US generic tariff reprieve on the rocks as Trump proposes 100% rate in 2028

pharminent July 22, 2026
  • Policy / Pricing

UK commits to pharma IP protection in Swiss trade deal

pharminent July 16, 2026
© 2026 All rights reserved. | ReviewNews by AF themes.